NIH Closes Doors for Secret Grant Review Sessions
Published Date: 5/12/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in late May and June 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research institutions waiting on grants should note these dates as they impact funding decisions.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Grant review dates affect applicants
The Center for Scientific Review will hold closed virtual grant-review meetings on May 29, 2026; June 11, 2026; June 15-16, 2026; and June 16, 2026. If you are a scientist or research institution waiting on NIH grant decisions, these meetings set the dates when your applications will be reviewed and therefore affect the timing of funding decisions.
Confidentiality protections for applicants
The meetings are closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property like patentable material, and personal information about individuals linked to grant applications. This protects applicants' proprietary information and personal privacy during the review process.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
2026-09852 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting personal and trade secrets. Scientists applying for grants and the research community should note these dates as they impact funding decisions.
2026-09324 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding virtual meetings on June 22, 2026, to review grant applications and share important updates. These meetings affect researchers and organizations seeking funding, with some sessions open to the public online and others closed to protect privacy. No new funding amounts are announced, but the grant review could impact future research support.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer and other diseases by turning off some ‘brakes’ inside them. This could lead to stronger, smarter treatments for cancer, infections, and autoimmune problems. Companies interested in licensing this tech should act soon to help bring these powerful therapies to patients and the market.
Previous / Next Documents
Previous: 2026-09322 — Certain Crystalline Silicon Photovoltaic Products From Taiwan: Preliminary Results of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce checked if solar products from Taiwan were being sold too cheaply in the U.S. from Feb 2024 to Jan 2025 and found they were not. This means no extra taxes (antidumping duties) will be added for now. Companies involved, especially EEPV Corp., can share their thoughts before the final decision.
Next: 2026-09324 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding virtual meetings on June 22, 2026, to review grant applications and share important updates. These meetings affect researchers and organizations seeking funding, with some sessions open to the public online and others closed to protect privacy. No new funding amounts are announced, but the grant review could impact future research support.